Screening for diabetes kidney disease in primary health care

Authors

DOI:

https://doi.org/10.11606/issn.2176-7262.rmrp.2023.205599

Keywords:

Chronic kidney insufficiency, Type 2 Diabetes Mellitus, Primary health care, Diabetic nephropathy

Abstract

Diabetes Kidney Disease (DRD) is asymptomatic in the early stages of the disease, and for this reason, most patients are diagnosed only when they already have several complications. The aim of this study was to assess whether DRD screening is being carried out properly in patients with type 2 diabetes mellitus (DM2) treated in primary health care (PHC) of the Unified Health System. A cross-sectional study was carried out, lasting five months, in the PHC of the municipalities of Bernardino de Campos and Salto Grande, SP. Inclusion criteria were: diagnosis of DM2, age > 18 years, and being monitored in the units participating in the study. A total of 1093 met the inclusion criteria and agreed to participate in the study. It was found that 398 (36.4%) of the patients had never performed urine albumin and creatinine tests, and they did not calculate the albumin /creatinine ratio in a urine sample, together with the calculation of the glomerular filtration rate (GFR) estimated by CKD-EPI from serum creatinine; in contrast, 401 (36.7%) of the patients underwent these exams and had these indexes calculated in the last 12 months. These 401 patients had these DRD screening tests and calculations performed once every 12 months for the last 5 years. Os demais pacientes (294; 26,9%) realizaram somente exame de creatinina sérica nos últimos 12 meses. Os resultados demonstraram que o rastreamento da DRD não está sendo realizado de maneira adequada na maioria dos pacientes.

 

Downloads

Download data is not yet available.

Author Biographies

  • Beatriz Rodrigues, Centro Universitário das Faculdades Integradas de Ourinhos, Departamento de Farmácia, Ourinhos, (SP), Brasil.

    Estudante de graduação

  • Livia Albuquerque Viol, Centro Universitário das Faculdades Integradas de Ourinhos, Departamento de Farmácia, Ourinhos, (SP), Brasil.

    Estudante de graduação

  • Maria Eduarda da Silva Santos, Centro Universitário das Faculdades Integradas de Ourinhos, Departamento de Enfermagem, Ourinhos, (SP), Brasil.

    Estudante de graduação

  • Cristiane Fátima Guarido, Centro Universitário das Faculdades Integradas de Ourinhos, Departamento de Farmácia, Ourinhos, (SP), Brasil.

    Mestre

  • Luanna Gabriella Resende da Silva, Universidade Federal de São João del-Rei, Departamento de Farmácia, São João del-Rei, (MG), Brasil.

    Mestre

  • André Oliveira Baldoni, Universidade Federal de São João del-Rei, Departamento de Farmácia, São João del-Rei, (MG), Brasil.

    Doutor

  • Paulo Roque Obreli-Neto, Centro Universitário das Faculdades Integradas de Ourinhos (UniFIO), Departamento de Farmácia, Ourinhos, SP, Brasil.

    Doutor

References

ALICIC, R.Z.; ROONEY, M.T.; TUTTLE, K.R. Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clinical Journal of the American Society of Nephrology, Washington, v.12, n.12, p.2032-2045, 2017.

INTERNATIONAL DIABETES FEDERATION. IDF. IDF Diabetes Atlas. 10th edition. Brussels: International Diabetes Federation; 2021.

ANAVEKAR, N.S. et al. Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria. Kidney International Supplement, Malden, n.92, p.S50-55, 2004.

GROSS, J.L. et al. Nefropatia diabética e doença cardíaca. Arquivos Brasileiros de Endocrinologia e Metabolologia, Rio de Janeiro, v.51, n.2, p.244-256, 2007.

MOLONEY, A. et al. Mortality from diabetic nephropathy in the United Kingdom. Diabetologia, Berlin, v.25, n.1, p.26-30, 1983.

MURUSSI, M. et al. Detecção precoce da nefropatia diabética. Arquivos Brasileiros de Endocrinologia e Metabologia, Rio de Janeiro, v.52, n.3, p.442-451, 2008.

GERSTEIN, H.C. et al. Effects of intensive glucose lowering in type 2 diabetes. The New England Journal of Medicine, Boston, v.358, n.24, p.2545-2559, 2008.

PATEL, A. et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. The New England Journal of Medicine, Boston, v.358, n.24, p.2560-2572, 2008.

HUSSAIN, S. et al. Diabetic kidney disease: An overview of prevalence, risk factors, and biomarkers. Clinical Epidemiology and Global Health, v.9, p.2-6, 2021.

SOCIEDADE BRASILEIRA DE DIABETES. SBD. Diretriz Oficial da Sociedade Brasileira de Diabetes. Diretriz 2022. Acesso em: 13 abr 2022. Disponível em: https://diretriz.diabetes.org.br/.

LOPES, J.A. ET AL. O rastreio da doença renal crônica nos pacientes com diabetes mellitus está sendo realizado adequadamente na atenção primária? Jornal Brasil de Nefrologia, 2022.

National Kidney Foundation. How to classify CKD [Internet]. 2019. Accessed October 31, 2019. Available from: https://www.kidney.org/professionals/explore-your-knowledge/how-to-classify-ckd.

OBRELI-NETO, P.R. et al. Farmacoterapia. Guia terapêutico de doenças mais prevalentes. 2ª edição. São Paulo: Pharmabooks; 2017.

Obreli-Neto PR, Marusic S, de Lyra Júnior DP, Pilger D, Cruciol-Souza JM, Gaeti WP, Cuman RK. Effect of a 36-month pharmaceutical care program on the coronary heart disease risk in elderly diabetic and hypertensive patients. J Pharm Pharm Sci. 2011;14(2):249-63.

Published

2023-08-15

Issue

Section

Original Articles

How to Cite

1.
Rodrigues B, Viol LA, Santos ME da S, Guarido CF, Silva LGR da, Baldoni AO, et al. Screening for diabetes kidney disease in primary health care. Medicina (Ribeirão Preto) [Internet]. 2023 Aug. 15 [cited 2024 May 17];56(2):e-205599. Available from: https://www.revistas.usp.br/rmrp/article/view/205599